Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Universitat Pompeu Fabra
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Pompeu Fabra (4)
2024
-
Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study
Clinical Genitourinary Cancer, Vol. 22, Núm. 5
2021
-
CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
Cancer Immunology Research, Vol. 9, Núm. 12, pp. 1476-1490
2019
-
Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
OncoImmunology, Vol. 8, Núm. 7
-
RRAS2 shapes the TCR repertoire by setting the threshold for negative selection
The Journal of experimental medicine, Vol. 216, Núm. 10, pp. 2427-2447